Skip to main content
Cellular Oncology: the Official Journal of the International Society for Cellular Oncology logoLink to Cellular Oncology: the Official Journal of the International Society for Cellular Oncology
. 2010 Feb 4;32(1-2):43–56. doi: 10.3233/CLO-2009-0493

Promiscuous Behavior of HPV16E6 Specific T Cell Receptor Beta Chains Hampers Functional Expression in TCR Transgenic T Cells, Which Can Be Restored in Part by Genetic Modification

Kirsten B J Scholten 1, Janneke J Ruizendaal 1, Marcus Graf 2, Thomas Schoedl 2, Duco Kramer 1, Chris J L M Meijer 1, Stephen Man 3, Erik Hooijberg 1,*
PMCID: PMC4619291  PMID: 20208133

Abstract

Background: T cell receptor gene transfer is a promising strategy to treat patients suffering from HPV induced malignancies. Therefore we isolated the TCRαβ open reading frames of an HPV16E6 specific CTL clone and generated TCR transgenic T cells. In general low level expression of the transgenic TCR in recipient human T cells is observed as well as the formation of mixed TCRs dimers. Here we addressed both issues employing three different expression platforms.

Methods: We isolated the HVP16E6 specific TCRα and TCRβ open reading frames and retrovirally transduced human T cells with either wild-type (wt), or codon-modified (cm) chains to achieve enhanced TCR expression levels, or used codon-modification in combination with cysteinization (cmCys) of TCRs to facilitate preferential pairing of the introduced TCRα and TCRβ chains.

Results: Careful analysis of recipient T cells carrying the HPV16E6 TCRβ and endogenous TCR chains revealed the transgenic TCRβ chain to behave very promiscuously. Further analysis showed that the percentage of tetramer positive T cells in codon-modified/cysteinized TCR transgenic T cells was four-fold higher compared to wild-type and two-fold higher compared to codon-modification only. Functional activity, as determined by IFN-γ production, was high in cmCysTCR transgenic T cells, where it was low in cm and wt TCR transgenic T cells. Recognition of endogenously processed HPV16E6 antigen by cmCysTCR transgenic T cells was confirmed in a cytotoxicity assay.

Conclusions: Promiscuous behavior of the HPV16E6 specific TCRβ chain can in part be forced back into specific action in TCR transgenic T cells by codon modification in combination with the inclusion of an extra cysteine in the TCR chains.

Keywords: Immunotherapy, cervical carcinoma, adoptive transfer, T cell receptors


Articles from Cellular Oncology : the Official Journal of the International Society for Cellular Oncology are provided here courtesy of Wiley

RESOURCES